Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
JABAL OMAR DEVELOPMENT COMPANY | 4250 | Saudi Arabian S.E. | 2,348,501 | 24.8 SAR | Stock |
News (314)
Companies (1)
Jabal Omar Development Co SJSC is a Saudi Arabia-based real estate development company. The Companyâs main activity is to own Jabal Omar area adjacent to the western side of the Holy Mosque Square and develop it into plots of land to manage, invest, sel ...
Insiders
Omar Syed Ishrak is the founder of Compute Health Acquisition Corp.
(founded in 2020) where he held the title of Chairman.
He currently holds the position of Chairman & Chief Executive Officer at Medtronic Trading NL BV.
Additionally, he is the Chairman at Biofourmis, Inc. (since 2022), Co-Chairman at Allurion Technologies, Inc. (since 2023), Independent Director at Amgen, Inc. (since 2021), Independent Director at Intel Corp.
(since 2017), Director at Cargill, Inc. (since 2021), Director at Insightec Ltd.
(since 2022), and Trustee at Asia Society (since 2021).
Dr. Ishrak has also held former positions including Chairman & Chief Executive Officer at Medtronic, Inc. (2011-2020), President & Chief Executive Officer at Health Care Systems, Inc., President & Chief Executive Officer at Clinical Systems, Inc., President & Chief Executive Officer at GE Healthcare, Inc. (2009-2011), President & Chief Executive Officer at GE Healthcare Clinical Systems (Wisconsin) (2005-2008), and Executive Chairman at Medtronic Ltd.
and Medtronic Plc (2011-2020).
He has also served as a Senior Vice President at GE Aerospace, a Trustee at Minnesota Public Radio, and General Manager at Ultrasound, Inc. Dr. Ishrak received his undergraduate and doctorate degrees from King's College London.
Omar Omar is currently working as a High Yield Credit Research Analyst at Barclays Capital Securities Ltd.
He graduated from The University of Edinburgh in 2017 with a graduate degree and from The University of Dundee in 2016 with an undergraduate degree.
Aliff Omar is a Senior Director of Investment at Ekuinas.
He joined the company as a Director, Investment in July 2017 covering the energy and consumer space.
He is a member of the Investment Committee and Management Committee.
Aliff carries with him over 14 years’ experience in corporate advisory and deal-making.
Prior to joining Ekuinas, Aliff was a Director of Investment Banking at UBS AG.
He led a number of M&A and Capital Markets transactions in Malaysia and across Southeast Asia, advising corporates within the energy, financial institutions, infrastructure & utility and real estate sectors.
Before UBS, Aliff was with the Regional M&A team of CIMB Investment Bank and the Investment Banking Division of Maybank Investment Bank.
Aliff graduated with a BSc in Industrial Engineering & Management Sciences (Cum Laude) with a second major in Economics from Northwestern University and an MPhil in Finance from University of Cambridge.
Omar D.
Perez is the founder of Nodality, Inc. founded in 2003.
He worked as a Director-Diagnostics, Research & Development at Tocagen, Inc. and as a Director-Phospho Protein Flow Cytometry Group at Stanford Health Care.
Dr. Perez holds a doctorate degree from Stanford University, which he received in 2002, and an undergraduate degree from the University of California, Berkeley, which he received in 1999.
No results for this search
- Stock Market
- Advanced search
- Omar Ishrak